1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. LARIMAR THERAPEUTICS INC
Larimar Therapeutics Inc XNAS: LRMR
3.57 0.04 (1.13%)
4.4M

XNAS 30 Jul, 2025 5:30 PM (EDT)

Board Meeting
The next board meeting for Larimar Therapeutics Inc is on 08 Aug 2025 for the purpose of Larimar Therapeutics Inc Second Quarter Earnings Results for 2025 See details


Insider Trading disclosures for Larimar Therapeutics Inc

The latest disclosure was made by Flynn E James in Larimar Therapeutics Inc where a trade of 19,000 Stock Option (Right to Buy) done was reported to US exchanges on May 13, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Flynn E James Director, Ten Percent Owner, * Director by Deputization Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2025 19,000 19,000 - - Stock Option (Right to Buy)
Thomas Edward Hamilton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2025 19,000 19,000 - - Stock Option (Right to Buy)
Joseph Truitt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2025 19,000 19,000 - - Stock Option (Right to Buy)
Jonathan S. Leff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2025 19,000 19,000 - - Stock Option (Right to Buy)
Jeffrey W. Sherman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2025 19,000 19,000 - - Stock Option (Right to Buy)
Frank E. Thomas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2025 19,000 19,000 - - Stock Option (Right to Buy)
Gopi Shankar Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2025 23,306 50,806 - 0 Common Stock
Gopi Shankar Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2025 139,838 139,838 - - Stock Option (Right to Buy)
Carole Ben-Maimon Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2025 546,000 546,000 - - Stock Option (Right to Buy)
Carole Ben-Maimon Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2025 91,000 387,208 - 0 Common Stock
Michael Celano Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2025 34,185 178,181 - 0 Common Stock
Michael Celano Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2025 205,111 205,111 - - Stock Option (Right to Buy)
Jeffrey W. Sherman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2024 19,000 19,000 - - Stock Option (Right to Buy)
Frank E. Thomas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2024 19,000 19,000 - - Stock Option (Right to Buy)
Jonathan S. Leff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2024 19,000 19,000 - - Stock Option (Right to Buy)
Joseph Truitt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2024 19,000 19,000 - - Stock Option (Right to Buy)
Flynn E James Director, Ten Percent Owner, * Director by Deputization Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2024 19,000 19,000 - - Stock Option (Right to Buy)
Thomas Edward Hamilton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2024 19,000 19,000 - - Stock Option (Right to Buy)
James Flynn E Director, Ten Percent Owner, * Director by Deputization Purchase of securities on an exchange or from another person at price $ 8.74 per share. 16 Feb 2024 1,430,206 6,151,406 - 8.7 12,500,000 Common Stock
E Flynn James Director, Ten Percent Owner, * Director by Deputization Purchase of securities on an exchange or from another person at price $ 8.74 per share. 16 Feb 2024 1,430,205 4,207,982 - 8.7 12,499,992 Common Stock
Flynn James E Director, Ten Percent Owner, * Director by Deputization Purchase of securities on an exchange or from another person at price $ 8.74 per share. 16 Feb 2024 1,430,206 6,151,389 - 8.7 12,500,000 Common Stock
Thomas Edward Hamilton Director Purchase of securities on an exchange or from another person at price $ 8.74 per share. 16 Feb 2024 57,208 564,798 - 8.7 499,998 Common Stock
Frank E. Thomas Director Purchase of securities on an exchange or from another person at price $ 11.00 per share. 14 Feb 2024 2,000 2,000 - 11 22,000 Common Stock
Celano Michael Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2024 31,250 143,996 - 0 Common Stock
Carole Ben-Maimon Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2024 66,125 332,954 - 0 Common Stock
Michael Celano Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2024 187,500 187,500 - - Stock Option (Right to Buy)
Gopi Shankar Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2024 22,500 27,500 - 0 Common Stock
Gopi Shankar Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2024 135,000 135,000 - - Stock Option (Right to Buy)
Carole Ben-Maimon Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2024 396,750 396,750 - - Stock Option (Right to Buy)
Shankar Gopi Chief Development Officer Purchase of securities on an exchange or from another person at price $ 3.73 per share. 07 Dec 2023 5,000 5,000 - 3.7 18,662 Common Stock
Michael Celano Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 3.73 per share. 17 May 2023 5,000 112,746 - 3.7 18,632 Common Stock
Joseph Truitt Director Purchase of securities on an exchange or from another person at price $ 3.73 per share. 17 May 2023 2,750 2,750 - 3.7 10,258 Common Stock
Carole Ben-Maimon Director, President and CEO Purchase of securities on an exchange or from another person at price $ 3.70 per share. 17 May 2023 5,000 266,829 - 3.7 18,525 Common Stock
Joseph Truitt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 May 2023 8,300 8,300 - - Stock Option (Right to Buy)
Flynn James E Director, Ten Percent Owner, * Director by Deputization Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 May 2023 8,300 8,300 - - Stock Option (Right to Buy)
Thomas Edward Hamilton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 May 2023 8,300 8,300 - - Stock Option (Right to Buy)
Jonathan S. Leff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 May 2023 8,300 8,300 - - Stock Option (Right to Buy)
Frank E. Thomas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 May 2023 8,300 8,300 - - Stock Option (Right to Buy)
Gopi Shankar Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2023 180,000 180,000 - - Stock Option (Right to Buy)
Michael Celano Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 120,000 120,000 - - Stock Option (Right to Buy)
Michael Celano Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 76,000 107,746 - 0 Common Stock
Carole Ben-Maimon Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 205,000 261,829 - 0 Common Stock
Carole Ben-Maimon Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 325,000 325,000 - - Stock Option (Right to Buy)
Thomas Edward Hamilton Director Purchase of securities on an exchange or from another person at price $ 3.15 per share. 16 Sep 2022 317,460 507,590 - 3.2 999,999 Common Stock
Michael Celano Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 3.15 per share. 16 Sep 2022 31,746 31,746 - 3.2 100,000 Common Stock
Carole Ben-Maimon Director, President and CEO Purchase of securities on an exchange or from another person at price $ 3.15 per share. 16 Sep 2022 31,746 56,829 - 3.2 100,000 Common Stock
Carole Ben-Maimon Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2022 40,000 40,000 - - Stock Option (Right to Buy)
Joseph Truitt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2022 8,300 8,300 - - Stock Option (Right to Buy)
Michael Celano Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2022 20,000 20,000 - - Stock Option (Right to Buy)
Peter Barrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2022 8,300 8,300 - - Stock Option (Right to Buy)
Jonathan S. Leff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2022 8,300 8,300 - - Stock Option (Right to Buy)
Frank E. Thomas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2022 8,300 8,300 - - Stock Option (Right to Buy)
Thomas Edward Hamilton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2022 8,300 8,300 - - Stock Option (Right to Buy)
Michael Celano Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2022 80,000 80,000 - - Stock Option (Right to Buy)
Carole Ben-Maimon Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2022 182,000 182,000 - - Stock Option (Right to Buy)
Thomas Edward Hamilton Director Purchase of securities on an exchange or from another person at price $ 8.75 per share. 30 Jun 2021 56,710 190,130 - 8.8 496,213 Common Stock
Thomas Edward Hamilton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2021 8,300 8,300 - - Stock Option (right to buy)
Frank E. Thomas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2021 8,300 8,300 - - Stock Option (right to buy)
Jonathan S. Leff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2021 8,300 8,300 - - Stock Option (right to buy)
Peter Barrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2021 8,300 8,300 - - Stock Option (right to buy)
Joseph Truitt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2021 8,300 8,300 - - Stock Option (right to buy)
Thomas O. Daniel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2021 8,300 8,300 - - Stock Option (right to buy)
Michael Celano Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2021 42,000 42,000 - - Stock Option (Right to Buy)
Carole Ben-Maimon Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2021 106,700 106,700 - - Stock Option (Right to Buy)
Jonathan S. Leff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Sep 2020 16,600 16,600 - - Stock Option (right to buy)
Peter Barrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Sep 2020 16,600 16,600 - - Stock Option (right to buy)
Michael Celano Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Sep 2020 84,100 84,100 - - Stock Option (right to buy)
Joseph Truitt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Sep 2020 16,600 16,600 - - Stock Option (right to buy)
Carole Ben-Maimon Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Sep 2020 411,400 411,400 - - Stock Option (right to buy)
Thomas O. Daniel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Sep 2020 16,600 16,600 - - Stock Option (right to buy)
Thomas Hamilton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Sep 2020 16,600 16,600 - - Stock Option (right to buy)
Frank E. Thomas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Sep 2020 16,600 16,600 - - Stock Option (right to buy)
Carole Ben-Maimon Director, President and CEO Other type of transaction at price $ 0.00 per share. 26 Jun 2020 25,083 25,083 - 0 Common Stock
Thomas Hamilton Director Other type of transaction at price $ 0.00 per share. 26 Jun 2020 159,433 292,853 - 0 Common Stock
Thomas Hamilton Director Other type of transaction at price $ 0.00 per share. 26 Jun 2020 133,420 133,420 - 0 Common Stock
Michael Celano Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2020 60,479 60,479 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures